site stats

Ktra investor relations

WebApr 6, 2024 · Kintara Therapeutics (KTRA) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results ... WebOct 14, 2024 · Kintara Therapeutics, Inc. (NASDAQ:KTRA) announced fiscal year 2024 financial and operational results in a September 29 th press release and filed its 10-K with the SEC. Highlights for the fourth...

Investor Relations :: Kintara Therapeutics, Inc. (KTRA)

WebPSG Konsult delivered a 5% increase in recurring headline earnings per share and a return on equity of 22.7% for the current year. Total assets under management increased by 13% to R354.1 billion, comprising assets … WebKTRA Earnings Forecast. Next quarter’s earnings estimate for KTRA is -$0.10 with a range of -$0.10 to -$0.10. The previous quarter’s EPS was -$2.10. KTRA beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.76% of the time in the same period. In the last calendar year KTRA has ... design and mental health https://arcobalenocervia.com

Kintara Therapeutics, Inc. Common Stock (KTRA) - Nasdaq

WebKintara Announces Closing of $15.0 million Offering Priced at a Premium to Market. PR Newswire. Sep-27-21 05:04AM. KTRA: 2Q:21 Update. Zacks Small Cap Research. Sep-24-21 08:00AM. Kintara Announces $15.0 million Offering of Common Stock and Warrants Priced at a Premium to Market. PR Newswire -21.43%. WebApr 11, 2024 · Kintara Therapeutics Inc KTRA Executive Morningstar Rating Rating as of Feb 17, 2024 Quote Chart Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Financials Valuation... WebApr 4, 2024 · As of April 03, 2024, Kintara Therapeutics Inc had a $5.9 million market capitalization, putting it in the 8th percentile of companies in the Biotechnology & Medical Research industry. Kintara Therapeutics Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. chubbottomlover twitter

KTRA Kintara Therapeutics, Inc. - Seeking Alpha

Category:Kintara Therapeutics Inc. (KTRA) Message Board InvestorsHub

Tags:Ktra investor relations

Ktra investor relations

Is Kintara Therapeutics Inc (KTRA) Stock a Good Investment?

Web(+0.75%) Kintara Therapeutics, Inc. (KTRA) NasdaqCM - NasdaqCM Delayed Price. Currency in USD Follow 2W 10W 9M 3.0800 -0.1500 (-4.64%) At close: 02:58PM EDT 3.1200 +0.04 … WebFeb 9, 2024 · Kintara Therapeutics, Inc. Common Stock (KTRA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Ktra investor relations

Did you know?

WebAspen was founded in 2024 with $6.5 million in seed funding led by Domain Associates and Axon Ventures and included Alexandria Venture Investments, ARCH Venture Partners, OrbiMed, and Section 32. In early 2024 the company closed a Series A round of $70 million led by OrbiMed and included ARCH Venture Partners, Frazier Healthcare Partners ... WebApr 12, 2024 · Telenor ASA appointed Frank Maao as senior vice president for capital markets and investor relations, according to a statement. Maao comes from the position as a senior equity research analyst at ...

WebApr 14, 2024 · A high-level overview of Kintara Therapeutics, Inc. (KTRA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment … WebFind the latest Kintara Therapeutics, Inc. (KTRA) stock quote, history, news and other vital information to help you with your stock trading and investing.

Web2024 Full Year Results & Reports. Mayne Pharma 2024 Annual Report. FY21 Results Media Release. FY21 Results Presentation. WebApr 10, 2024 · See the latest Kintara Therapeutics Inc stock price (NASDAQ:KTRA), related news, valuation, dividends and more to help you make your investing decisions.

WebMay 10, 2024 · Kintara Therapeutics, Inc. Common Stock (KTRA) Nasdaq Listed DATA AS OF May 10, 2024 OUT OF COMPLIANCE Add to Watchlist Add to Portfolio Quotes …

WebApr 6, 2024 · Short interest is the volume of Kintara Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 5,200 shares of KTRA short. 0.32% of Kintara Therapeutics' shares are currently sold short. Learn More on Kintara Therapeutics' current short interest. chubb oracle service cloudWebInvestors Investors. Overview; Analyst Coverage; News / Events. Overview; Press Releases; IR Calendar; Email Alerts; Company Info. Overview; Profile; Presentations; Management … Please fill out the form below to receive company press releases via email when … Presentations - Investor Relations :: Kintara Therapeutics, Inc. (KTRA) Investor Tools . Email Alerts; Contacts; RSS News Feed; Company Information; … Kintara Therapeutics to Present at the 2024 BIO CEO & Investor Conference . Jan 30, … chubb orcaWebMoved Permanently. The document has moved here. chubb oracleWebJun 21, 2024 · KTRA Earnings Date Latest Press Release Published Jun 21, 2024 Kintara Therapeutics to Present at the Alliance Global Partners Summer Healthcare Conference … design and order t-shirts onlineWeb1 day ago · In trading on Thursday, shares of Berkshire Hills Bancorp Inc (Symbol: BHLB) touched a new 52-week low of $23.03/share. That's a $8.60 share price drop, or -27.19% decline from the 52-week high of ... chubb organization chartWebMar 15, 2024 · Kintara Therapeutics, Inc. Nasdaq: KTRA Day Range View Investor Relations View Investor Presentation design and other types of fixationWebApr 14, 2024 · Kintara Therapeutics, Inc. (KTRA) Stock Price Today, Quote & News Seeking Alpha Premium My Portfolio My Authors Top Stocks Latest News Markets Stock Ideas Dividends ETFs Education KTRA... chubb o\u0027reilly cancer springfield mo